FDA Defends Ephedra Ban Procedures In Nutraceutical Case Filing

FDA followed required rulemaking procedures in issuing a final rule that banned ephedra dietary supplements, the agency argues in a response brief filed in its ongoing legal battle with Nutraceutical Corp

More from Archive

More from Pink Sheet